Circulating secretory phospholipase A2 activity predicts recurrent events in patients with severe acute coronary syndromes.

@article{Mallat2005CirculatingSP,
  title={Circulating secretory phospholipase A2 activity predicts recurrent events in patients with severe acute coronary syndromes.},
  author={Ziad Mallat and Philippe Gabriel Steg and Jo{\"e}lle B{\'e}nessiano and M Tanguy and Keith A. A. Fox and J. -P. Collet and Omar H Dabbous and P. G. Henry and Kathryn F. Carruthers and Anne Dauphin and Carla Sibella Arguelles and Jo{\"e}lle Masliah and B{\'e}n{\'e}dicte Hugel and Gilles Montalescot and J. -M. Freyssinet and Bernard Asselain and Alain Tedgui},
  journal={Journal of the American College of Cardiology},
  year={2005},
  volume={46 7},
  pages={1249-57}
}
OBJECTIVES The purpose of this study was to determine the prognostic value of circulating secretory phospholipase A2 (sPLA2) activity in patients with acute coronary syndromes (ACS). BACKGROUND The plasma level of type IIA sPLA2 is a risk factor for coronary artery disease (CAD) and is associated with adverse outcomes in patients with stable CAD. The prognostic impact of sPLA2 in patients with ACS is unknown. METHODS Secretory phospholipase A2 antigen levels and activity were measured in… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 65 extracted citations

Similar Papers

Loading similar papers…